ConBioChem: Continuous bio-production of commodity chemicals

Lead Research Organisation: University College London
Department Name: Biochemical Engineering

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

This ambitious, multidisciplinary project will establish generic design procedures to underpin the introduction of continuous bio-manufacturing processes for commodity/platform chemicals and added value intermediates. Crucial improvements in operational stability will be delivered through Synthetic Biology, to construct genetically stable chassis strains. Metabolic modelling will be used to design rational strain engineering and processing strategies, to divert cellular metabolism away from growth and towards product formation, to deliver critical improvements in product yields. The metabolic models will be integrated into multiscale models, involving reactor and process models and LCA, to enable seamless, integrated design of both the organisms and the processes, so that both will operate synergistically for maximal commercial benefit and sustainability. Success will be measured through technoeconomic analysis to deliver commercially relevant design approaches.

Planned Impact

As described in proposal submitted to IUK.
 
Description The overarching goals of the ConBioChem project (Continuous Bioproduction of Commodity Chemicals) are to:

(1) Create synthetic biology solutions to the problem of low yields and operational instability of microorganisms in continuous culture.
(2) Establish multiscale models to underpin design of commercially viable, sustainable bioprocesses.
(3) Create innovative, continuous bioprocesses ready for demonstration with our partners:

The project started in October 2016 and will run for 5 years (with possible no-cost extension due to Covid-19 under evaluation). It involves partners at the University of Nottingham (lead) and Cambridge University. UCL progress against the overarching objectives are as follows:

(1) To improve the stability of the chosen host organism, E. coli, in continuous culture a number of genetic 'addiction systems' have been identified in the literature. These have been cloned and expressed in a series of plasmids which also contain a Red Fluorescent Protein (RFP) marker so that both plasmid loss and DNA mutation in the gene of interest can be monitored. These have been transformed into a metabolically engineered E. coli strain (from Nottingham) that produces citramalate, CM, (a precursor to the target product methacrylic acid, MMA) and the 'best' addiction system identified. A small scale, high throughput, system for monitoring plasmid stability that is predictive of bioreactor scale continuous cultures, has also been established and verified (based on (2) below).

(2) A full kinetic model that describes substrate utilisation, cell growth, product formation and allows quantification of plasmid instability batch, fed-batch and continuous CM fermentation processes has been developed. This has been validated against multiple fermentation runs, especially continuous cultures performed at different initial glucose concentrations and dilution rates. The model is being used to inform related Life Cycle Analysis (LCA) work at Nottingham and metabolic modelling work performed at Cambridge (we are also undertaking some gene knock-out experiments to help confirm the metabolic modelling predictions from the group at Cambridge).

(3) The most recent work has focused on building a model-based, on-line monitoring and control system for continuous CM fermentations. The novel mid-IR on-line monitoring system purchased on the grant has been shown to be able to measure a range of products and metabolites at concentrations of <1 g/L. Chemometric models have been established to simultaneously measure biomass concentration, CM concentration and glucose concentration using a variety of methods . The control system has been successfully implemented in a LabView environment at UCL and used to demonstrate on-line monitoring and control of glucose-limited cultures for CM production. The technology has also been transfered to the collaborators at Nottingham who are currently running the system for control of glucose levels in phosphate-limited cultures for production of an alternative product, 3-HB, as agreed with the consortium industrial partners
Exploitation Route The E coli host strain engineered for improved stability will be evaluated by the collaborating company partners. Commercialisation options for the plasmid additction systems (as kits) is being explored.
Sectors Chemicals,Manufacturing, including Industrial Biotechology

 
Description Findings have formed the basis of a synthetic biology start-up company - Twig Bio Limited.
First Year Of Impact 2022
Sector Chemicals,Environment,Manufacturing, including Industrial Biotechology
Impact Types Economic

 
Description Decarbonising The Acrylic Value Chain Via Resource Circularity
Amount £1,740,036 (GBP)
Funding ID EP/V038052/1 
Organisation Engineering and Physical Sciences Research Council (EPSRC) 
Sector Public
Country United Kingdom
Start 08/2021 
End 07/2026
 
Description Future Biomanufacturing Research Hub
Amount £10,284,509 (GBP)
Funding ID EP/S01778X/1 
Organisation Engineering and Physical Sciences Research Council (EPSRC) 
Sector Public
Country United Kingdom
Start 03/2019 
End 03/2026
 
Description [16-FAPESP-BE] Lignin valorization in cellulosic ethanol plants: biocatalytic conversion via ferulic acid to high value chemicals
Amount £2,082,438 (GBP)
Funding ID BB/P01738X/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 02/2017 
End 02/2022
 
Title Refining methods for multiple enzyme expression for developing enzyme cascades. 
Description The need for building multiple enzyme cascades or short pathways is central to several areas of biocatalysts and synthetic biology. We have used the developments made in this grant and extended these to the research in several other grant funded areas. We can use comparable plasmids to co-express two or more enzymes in the same cell and we have been building short operons where all the genes are expressed from a single promoter on the same mRNA. With the comparable plasmid approach we can adjust the amount of each of the expressed enzymes by choosing plasmid replicons of different copy numbers as well as using different strength promoters. With the operon constructions we can ensure that all the enzymes are expressed at the same time and largely to the same levels. 
Type Of Material Technology assay or reagent 
Provided To Others? Yes  
Impact The application of the methods and concepts described above has allowed us to create stable expression strains that don't need any antibiotic in continuous cultures. We have been able to balance the three different enzymes needed for functional cytochrome P450 expression. The technology is central now to several areas of our research for the synthesis of chiral small molecules for alkaloids, chiral amines and methyl transferases where several enzymes are needed to build the complex final compound. In several cases this can compete very favourably with synthetic organic chemistry pathways and in one example an 8 step chemical pathway was achieved in a three step enzyme pathway. 
 
Description AB Sugar (enzymatically enhanced sucrose extraction from sugar beet) 
Organisation AB Sugar
Country United Kingdom 
Sector Private 
PI Contribution A follow on PhD project was funded by the National Productivity Invesment Fund in collaboratio with AB Sugar. This exploits some of the thermostable enzymes identified in this project which are currently being investigated to enhance sugar extraction.
Collaborator Contribution AB Sugar have provided the sugar beet feedstock, have shared data on their large scale operations and the impact they see of enzymatic pretreatment of sugar beet at large scale. They have also provided an opportunity for the student concerneed and the PI to visit their Wissington biorefinery and see the facility in operation.
Impact To date we have constructed an experimental scale-down diffuser model at UCL. This is currently being validated but could be transfered to AB Sugar to support their process development programme.
Start Year 2018
 
Description University of Cambridge 
Organisation University of Cambridge
Department Department of Biochemistry
Country United Kingdom 
Sector Academic/University 
PI Contribution Project just getting underway. UCL will provide Cambridge with fermentation samples for metabolomic analysis.
Collaborator Contribution Cambridge will provide metabolic data and models that will ultimately used for model-based control of commodity chemicals production
Impact None to dae - project just getting started
Start Year 2016
 
Description University of Nottingham 
Organisation University of Nottingham
Country United Kingdom 
Sector Academic/University 
PI Contribution Preliminary modelling of Nottingham fermentation data.
Collaborator Contribution Provision of engineered cell lines making target product.
Impact Project is just getting underway. No outcomes yet.
Start Year 2016
 
Company Name TWIG BIO LIMITED 
Description Sustainability-focused synthetic biology company with machine learning as a core technology. 
Year Established 2022 
Impact None. New start-up.
Website https://www.twig.bio/